Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

UCB partners with Daiichi to bring epilepsy drug to Japan

Companies partner on expanding market for Vimpat

- PMLiVE

NICE backtracks on Gazyvaro rejection

Roche agrees to patient access scheme to help gain leukaemia recommendation

- PMLiVE

GSK names drug hunter challenge winners

Competition finds promising projects in anti-infectives, cancer and neurodegenerative diseases

- PMLiVE

GSK’s oncology president joins NuCana board

Paolo Paoletti also has experience in cancer research at Lilly

- PMLiVE

Building a business that is lean and specialised

Tuomo Pätsi on Celgene’s approach to access, marketing and the importance of culture

- PMLiVE

Merck: You need to win locally in consumer health

And company says it would consider targeted 'bolt-on' acquisitions

- PMLiVE

Succinct and ecancer team up on oncology education events

Will work together to support HCPs

- PMLiVE

Italy investigates Novartis vaccine after death toll reaches 13

Firms insist on the Fluad's safety, with 65 million doses given in the last 17 years

- PMLiVE

AIDS pandemic now at ‘the beginning of the end’

ONE Campaign says drug access is making the difference, but there's still more to do

- PMLiVE

AZ and Lilly start BACE inhibitor trial in Alzheimer’s

Early trials show promise for the BACE inhibitor AZD3293

- PMLiVE

Novartis’ Gilenya fails in difficult-to-treat form of MS

Drug no better than placebo as a treatment for primary progressive multiple sclerosis

- PMLiVE

Two new hires at Couch

And agency moves to Manchester

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links